Picture of Delta-Fly Pharma logo

4598 — Delta-Fly Pharma News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Table: Delta-Fly Pharma - 6-MTH parent results

Nov 14 (Reuters)- 
             Delta-Fly Pharma, Inc. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to   
                Sep 30, 2019        Sep 30, 2018       Mar 31, 2020  
                   LATEST             YEAR-AGO            LATEST     
                   RESULTS             RESULTS           FORECAST    
  Operating     loss 725 mln        loss 237 mln        loss 1.07    
  Recurring     loss 729 mln        loss 277 mln        loss 1.07    
  Net           loss 731 mln        loss 278 mln        loss 1.07    
  EPS          loss 165.18 yen     loss 77.29 yen    loss 244.85 yen 
  Ann Div                                NIL               NIL       
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL               NIL       
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T

Recent news on Delta-Fly Pharma

See all news